Navigation Links
Doctor Grilled In Court For False Report About Vioxx Health Risk

The doctor, who had dismissed increased risk of heart attack associated with Vioxx, has been accused by lawyers who argue that his views are 'out of the mainstream' as it is based on biased research //, funded by the drug company, Merck and Co.

Thomas Cona and John Mcdarby have sued the pharmaceutical company, stating that use of the drug had resulted in heart attacks. More than 10, 000 different lawsuits has been filed against the controversial Vioxx, on grounds of product liability. The product, originally intended for arthritis treatment was withdrawn from the market in the September of 2004.

The case was taken up for hearing recently. Attorney Mark Lanier questioned the motivation and educational qualifications of Merck expert witness Dr. Barry Rayburn during the cross-examination. He works as a cardiologist in the University of Alabama. He further stated that anyone who had not taken money from Merck would deserve to be called mainstream doctor.

The attorney who stands for Thomas Cona is the only who had won a case against Merck, last August. He enabled a Texas based widow, a user of Vioxx receive a multimillion-dollar jury award. Other similar trials that were taken up in the state and federal courts had ended up in favor of Merck.

Rayburn was peppered with questions about studies and articles that demonstrated an increased risk of heart attack in those who used Vioxx. This however was not included in the doctor’s testimony that was submitted in the court on Tuesday. To this Rayburn responded by saying that some of the articles or studies cited by Lanier were not included in his testimony because he 'felt it was important to look at things that were peer reviewed. I also looked at many studies we have not talked about'.

The close scrutiny by several other experts in a specific field confers the peer-reviewed studies, a higher credibility. Every attempt is made to ensure that the study was indeed desig ned and conducted in a systematic way, to meet the industry standards. The cardiologist pointed out to the study conducted on more than 28, 000 patients that had no evidence of increased heart attack or other cardiovascular complications.

In addition, Rob Gordon, a lawyer representing McDarby, grilled Rayburn about his legal work for Merck, his payment and involvement in other clinical trials conducted by the drug company.

Following a study, which showed for the first time that use of the drug for a period of 18 months, doubled the heart attack risk; the pain relief was withdrawn from the drug market.

The conclusion, according to the lawyers is that although it was known that the drug increased risk of heart attacks in users, the drug company failed to warn the users, compromising on patient safety for want of profit.


'"/>




Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Doctors needed urgently in Gujarat
3. Doctors operate upon patients in candlelight- latest from the quake scene
4. Doctors at risk- the ugly side of the noble profession
5. Doctors advice early anemia tests
6. Indian Doctor granted US patent on organ regeneration
7. Emphasis to ban Drugs ads by Doctors
8. Doctor samples come under the ambit of advertisement
9. Doctors not to accept gifts from drug companies
10. Gene testing kit specific for Doctors
11. Doctors warned of fluoride toxicity
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/21/2017)... ... January 21, 2017 , ... "ProDOF is the perfect set of tools for video editors ... in a scene," said Christina Austin - CEO of Pixel Film Studios. , Video ... create the illusion of a DSLR racking focus from one area into the next. ...
(Date:1/21/2017)... ... January 21, 2017 , ... Pacifica Graduate ... the electrifying line-up of events for its annual meeting “Coming Home 2017,” an ... “Coming Home 2017” will be held on Friday January 27 through Sunday, ...
(Date:1/21/2017)... Pekin, IL (PRWEB) , ... January 21, 2017 , ... ... disorders. Even when individuals experience the freedom of recovery, they often feel shame for ... abuse and post-traumatic stress disorder (PTSD). In the workshop, “Rising Strong in Life After ...
(Date:1/20/2017)... ... 20, 2017 , ... A new partnership between Goodwill® and Roadie, Inc. aims ... need, from clothes to couches to dressers and bicycles. Roadie — the national on-the-way ... nearest Goodwill donation center through February 28th. , “January is an exciting time ...
(Date:1/20/2017)... ... January 20, 2017 , ... Doctor C LLC, a company based ... ECRM trade show to continue the marketing and distribution of its product, The Right ... providing 400 percent better absorption than traditional vitamin C supplements. At the trade show, ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... Jan. 20, 2017  Palladian Health, a leading ... the launch of an opioid management program which ... opioids and helps stem the growing tide of ... to treat chronic non-cancer pain (back pain, neck ... and lack of evidence regarding long-term effectiveness. ...
(Date:1/20/2017)... VAE, January 20, 2017 ... Bedarf an Nothilfe   Die internationale humanitäre Stadt ... Hilfsgüter zu schaffen   Seine Hoheit ... der VAE sowie Herrscher von Dubai ... Stadt der Hilfe (International Humanitarian City IHC) zu verdreifachen, ...
(Date:1/19/2017)... LONDON , Jan. 19, 2017 ... 2022 Summary GlobalData,s new report, "Germany Cataract ... data on the Germany Cataract Surgery Devices market. The ... (in units) and average prices (USD) within market segements ... The report also provides company shares and distribution shares ...
Breaking Medicine Technology: